Ardelyx (ARDX) (ADRX) announced the appointment of Sue Hohenleitner as Chief Financial Officer, CFO, effective November 4, 2025. Hohenleitner most recently served as the Vice President and Chief Financial Officer of Johnson & Johnson (JNJ) Innovative Medicine North America
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX: